Radiation treatment can help reduce the recurrence of Merkel cell carcinoma, a rare and aggressive skin cancer, while chemotherapy does not appear to have any impact on recurrence or survival, according to a Kaiser Permanente study published online in the current issue of JAMA Dermatology.
The study presents one of the largest single-institution datasets on Merkel cell carcinoma, which occurs in about 1,500 people in the United States annually. Most such cancers occur on the sun-exposed skin of white males and are first diagnosed at age 75, on average. Using the Kaiser Permanente Northern California Cancer Registry, the researchers found that out of 218 cases of Kaiser Permanente patients who had Merkel cell carcinoma, those who had radiation treatment had a 70 percent lower risk of disease recurrence while chemotherapy did not appear to have any impact on recurrence or survival.
"We used our database to show what characteristics impact recurrence and survival in this very rare cancer," said the study's lead author Maryam M. Asgari, MD, MPH, of the Kaiser Permanente Division of Research. "The electronic records allowed us to identify patients with Merkel cell carcinoma, see how they were diagnosed and treated, and then follow them over time to see how their care affected their outcomes."
Using an electronic health record system, Kaiser Permanente HealthConnect, allowed the researchers to evaluate the relationships between cancer recurrence and survival with demographic information (age, sex, race, immunosuppression) and tumor characteristics (extent, size and location), as well as cancer work-ups (pathologic lymph node evaluation, imaging) and treatments (surgery, radiation and chemotherapy).
The study results also showed that immunosuppression and more advanced tumors were associated with worse survival rates related to Merkel cell carcinoma, and that pathological evaluation of the patient's lymph nodes also had a significant impact on outcomes.
Asgari noted that the success of different work-up and treatment protocols has been difficult to compare for rare cancers. "This research should help dermatologists and oncologists in caring for their patients with Merkel cell carcinomas," she said.
Explore further: Less invasive technique possible in vulvar cancer treatment
Medical Xpress on facebook
Related Stories
Sentinel lymph node biopsy predicts outcomes for Merkel cell carcinoma
Oct 03, 2011
Patients with Merkel Cell Carcinoma who underwent a procedure called sentinel lymph node biopsy (SNLB) had a lower risk of cancer recurrence after two years, according to a study by researchers from Fox Chase Cancer Center. ...
Study reveals two-fold higher incidence of non-melanoma skin cancers for HIV patients
Jan 29, 2013
HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal ...
Routine blood test predicts prognosis in aggressive skin cancer
Oct 31, 2012
A routine blood test may help predict survival in patients with an aggressive form of skin cancer known as Merkel cell carcinoma, according to new findings by Fox Chase Cancer Center researchers. The results will be presented ...
Less invasive technique possible in vulvar cancer treatment
Mar 26, 2014
A team of researchers from Women & Infants Hospital of Rhode Island commanded a national stage to present the results of a study evaluating the use of sentinel lymph node dissection in women with vulvar malignancies, and ...
Study finds least aggressive form of breast cancer still poses risk for death years later
Sep 18, 2012
Women with the most common and least aggressive subtype of breast cancer were still at risk of death from the disease more than 10 years after diagnosis, according to a Kaiser Permanente study published in the journal Cancer Ep ...
Recommended for you
ARRS: Women overestimate radiation risk from mammogram
1 hour ago
(HealthDay)—Women tend to overestimate the radiation risk associated with mammography, according to a study presented at the annual meeting of the American Roentgen Ray Society, held from May 4 to 9 in ...
Regular doctor visits may greatly diminish skin cancer deaths
3 hours ago
The risk of dying from the most dangerous type of skin cancer is significantly reduced with regular doctor visits, according to a Henry Ford Hospital study.
Researchers use DNA to build tool that may literally shine light on cancer
4 hours ago
Bioengineers at the University of Rome Tor Vergata and the University of Montreal have used DNA to develop a tool that detects and reacts to chemical changes caused by cancer cells and that may one day be ...
Ability to isolate and grow breast tissue stem cells could speed cancer research
6 hours ago
(Medical Xpress)—By carefully controlling the levels of two proteins, researchers at the Salk Institute have discovered how to keep mammary stem cells—those that can form breast tissue—alive and functioni ...
Study confirms clinical benefit for interleukin-2 immunotherapy in patients with advanced kidney cancer
6 hours ago
(Medical Xpress)—A retrospective study published online ahead of print in the medical journal Urology by a physician team from Roswell Park Cancer Institute (RPCI) found that patients with metastatic kidney cancer—even ...
Researchers discover 'bad' cholesterol contributes to cancer spread in the body
8 hours ago
(Medical Xpress)—In a world-first, University of Sydney researchers have discovered one of the main reasons behind why cancer spreads throughout the body - the help of 'bad' cholesterol.
User comments
© Medical Xpress 2011-2014, Science X network
Radiation treatment can help reduce the recurrence of Merkel cell carcinoma, a rare and aggressive skin cancer, while chemotherapy does not appear to have any impact on recurrence or survival, according to a Kaiser Permanente study published online in the current issue of JAMA Dermatology.
The study presents one of the largest single-institution datasets on Merkel cell carcinoma, which occurs in about 1,500 people in the United States annually. Most such cancers occur on the sun-exposed skin of white males and are first diagnosed at age 75, on average. Using the Kaiser Permanente Northern California Cancer Registry, the researchers found that out of 218 cases of Kaiser Permanente patients who had Merkel cell carcinoma, those who had radiation treatment had a 70 percent lower risk of disease recurrence while chemotherapy did not appear to have any impact on recurrence or survival.
"We used our database to show what characteristics impact recurrence and survival in this very rare cancer," said the study's lead author Maryam M. Asgari, MD, MPH, of the Kaiser Permanente Division of Research. "The electronic records allowed us to identify patients with Merkel cell carcinoma, see how they were diagnosed and treated, and then follow them over time to see how their care affected their outcomes."
Using an electronic health record system, Kaiser Permanente HealthConnect, allowed the researchers to evaluate the relationships between cancer recurrence and survival with demographic information (age, sex, race, immunosuppression) and tumor characteristics (extent, size and location), as well as cancer work-ups (pathologic lymph node evaluation, imaging) and treatments (surgery, radiation and chemotherapy).
The study results also showed that immunosuppression and more advanced tumors were associated with worse survival rates related to Merkel cell carcinoma, and that pathological evaluation of the patient's lymph nodes also had a significant impact on outcomes.
Asgari noted that the success of different work-up and treatment protocols has been difficult to compare for rare cancers. "This research should help dermatologists and oncologists in caring for their patients with Merkel cell carcinomas," she said.
Explore further: Less invasive technique possible in vulvar cancer treatment
Medical Xpress on facebook
Related Stories
Sentinel lymph node biopsy predicts outcomes for Merkel cell carcinoma
Oct 03, 2011
Patients with Merkel Cell Carcinoma who underwent a procedure called sentinel lymph node biopsy (SNLB) had a lower risk of cancer recurrence after two years, according to a study by researchers from Fox Chase Cancer Center. ...
Study reveals two-fold higher incidence of non-melanoma skin cancers for HIV patients
Jan 29, 2013
HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal ...
Routine blood test predicts prognosis in aggressive skin cancer
Oct 31, 2012
A routine blood test may help predict survival in patients with an aggressive form of skin cancer known as Merkel cell carcinoma, according to new findings by Fox Chase Cancer Center researchers. The results will be presented ...
Less invasive technique possible in vulvar cancer treatment
Mar 26, 2014
A team of researchers from Women & Infants Hospital of Rhode Island commanded a national stage to present the results of a study evaluating the use of sentinel lymph node dissection in women with vulvar malignancies, and ...
Study finds least aggressive form of breast cancer still poses risk for death years later
Sep 18, 2012
Women with the most common and least aggressive subtype of breast cancer were still at risk of death from the disease more than 10 years after diagnosis, according to a Kaiser Permanente study published in the journal Cancer Ep ...
Recommended for you
ARRS: Women overestimate radiation risk from mammogram
1 hour ago
(HealthDay)—Women tend to overestimate the radiation risk associated with mammography, according to a study presented at the annual meeting of the American Roentgen Ray Society, held from May 4 to 9 in ...
Regular doctor visits may greatly diminish skin cancer deaths
3 hours ago
The risk of dying from the most dangerous type of skin cancer is significantly reduced with regular doctor visits, according to a Henry Ford Hospital study.
Researchers use DNA to build tool that may literally shine light on cancer
4 hours ago
Bioengineers at the University of Rome Tor Vergata and the University of Montreal have used DNA to develop a tool that detects and reacts to chemical changes caused by cancer cells and that may one day be ...
Ability to isolate and grow breast tissue stem cells could speed cancer research
6 hours ago
(Medical Xpress)—By carefully controlling the levels of two proteins, researchers at the Salk Institute have discovered how to keep mammary stem cells—those that can form breast tissue—alive and functioni ...
Study confirms clinical benefit for interleukin-2 immunotherapy in patients with advanced kidney cancer
6 hours ago
(Medical Xpress)—A retrospective study published online ahead of print in the medical journal Urology by a physician team from Roswell Park Cancer Institute (RPCI) found that patients with metastatic kidney cancer—even ...
Researchers discover 'bad' cholesterol contributes to cancer spread in the body
8 hours ago
(Medical Xpress)—In a world-first, University of Sydney researchers have discovered one of the main reasons behind why cancer spreads throughout the body - the help of 'bad' cholesterol.
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment